Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nicholas J. Donato is active.

Publication


Featured researches published by Nicholas J. Donato.


Blood | 2005

Dasatinib (BMS-354825) in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Who Are Resistant or Intolerant to Imatinib: Update of a Phase I Study.

Charles L. Sawyers; Hagop M. Kantarjian; Neil P. Shah; Jorge Cortes; Ronald Paquette; Nicholas J. Donato; John Nicoll; Eric Bleickardt; Tai-Tsang Chen; Moshe Talpaz


Archive | 2013

BCR-ABL inhibition after loss of cytokine-mediated Stat-5 activation and protection from apoptosis -chain in BCR-ABL+human leukemic cells: association with β factor receptor Down-regulation of interleukin-3/granulocyte-macrophage colony-stimulating

Nicholas J. Donato; Ji Y. Wu; Ling Zhang; Hagop M. Kantarjian; Moshe Talpaz


Archive | 2013

apoptosis of chronic myelogenous leukemia cells Activation of a novel Bcr/Abl destruction pathway by WP1130 induces

Waldemar Priebe; Ji Wu; Nicholas J. Donato; Geoffrey Bartholomeusz; Moshe Talpaz; Vaibhav Kapuria; Ling Yuan Kong; Shimei Wang


Archive | 2013

mutation-dependent and -independent imatinib resistance Adaphostin-induced oxidative stress overcomes BCR/ABL

Judith E. Karp; Edward A. Sausville; Scott H. Kaufmann; Mercedes E. Gorre; Zeev Estrov; Nicholas J. Donato; Moshe Talpaz; Charles L. Sawyers; Kapil N. Bhalla; Joya Chandra; Jeannette Tracy; David A. Loegering; Karen S. Flatten; Srdan Verstovsek; Miloslav Beran


Archive | 2010

mutation-dependent and -independent imatinib resistance BCR/ABL Adaphostin-induced oxidative stress overcomes

Judith E. Karp; Edward A. Sausville; Scott H. Kaufmann; Mercedes E. Gorre; Zeev Estrov; Nicholas J. Donato; Moshe Talpaz; Charles L. Sawyers; Kapil N. Bhalla; Joya Chandra; Jeannette Tracy; David A. Loegering; Karen S. Flatten; Srdan Verstovsek; Miloslav Beran


Cancer Research | 2005

A role for Src-family kinases in imatinib resistant chronic myelogenous leukemia

Nicholas J. Donato; Ji Y. Wu; Ling Y. Kong; Francis Y. Lee; Moshe Talpaz


Archive | 2004

Composes pour traiter des maladies associees a une proliferation cellulaire

Waldemar Priebe; Nicholas J. Donato; Moshe Talpaz; Slawomir Szymanski; Izabela Fokt; Alexander Levitzki


Archive | 2004

Verbindungen zur behandlung von krankheiten mit zellproliferation

Waldemar Priebe; Nicholas J. Donato; Moshe Talpaz; Slawomir Szymanski; Izabela Fokt; Alexander Levitzki


Archive | 2004

Compounds for treating diseases of cell proliferation

Waldemar Priebe; Nicholas J. Donato; Moshe Talpaz; Slawomir Szymanski; Izabela Fokt; Alexander Levitzki


Archive | 2002

Utilisation d'inhibiteurs c-src seuls ou en combinaison avec sti571 pour le traitement de leucemies

Nicholas J. Donato; Doriano Fabbro; Paul W. Manley; Markus Warmuth; Michael Hallek; Moshe Talpaz; Ji Wu

Collaboration


Dive into the Nicholas J. Donato's collaboration.

Top Co-Authors

Avatar

Moshe Talpaz

University of Texas System

View shared research outputs
Top Co-Authors

Avatar

Waldemar Priebe

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar

Charles L. Sawyers

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Izabela Fokt

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Ji Wu

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Slawomir Szymanski

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Alexander Levitzki

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Hagop M. Kantarjian

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge